| Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial CR Divgi, N Pandit-Taskar, AA Jungbluth, VE Reuter, M Gönen, S Ruan, ... The lancet oncology 8 (4), 304-310, 2007 | 439 | 2007 |
| Targeting Lewis Y (LeY) in small cell lung cancer with a humanized monoclonal antibody, hu3S193: a pilot trial testing two dose levels LM Krug, DT Milton, AA Jungbluth, LC Chen, E Quaia, N Pandit-Taskar, ... Journal of Thoracic Oncology 2 (10), 947-952, 2007 | 45 | 2007 |
| Improved tumor imaging and therapy via iv IgG–mediated time-sequential modulation of neonatal Fc receptor JS Jaggi, JA Carrasquillo, SV Seshan, P Zanzonico, E Henke, A Nagel, ... The Journal of clinical investigation 117 (9), 2422-2430, 2007 | 38 | 2007 |
| Query optimization in a distributed hypercube database A Mowshowitz, A Kawaguchi, A Toce, A Nagel, G Bent, P Stone, ... Proceedings of the Fourth Annual Conference of ITA, 2010 | 11 | 2010 |
| The value of gamma camera and computed tomography data set coregistration to assess Lewis Y antigen targeting in small cell lung cancer by 111Indium-labeled humanized … E Quaia, LM Krug, N Pandit-Taskar, A Nagel, VE Reuter, J Humm, C Divgi European journal of radiology 67 (2), 292-299, 2008 | 8 | 2008 |
| Linear Programming in Database A Kawaguchi, A Nagel New Developments in Robotics Automation and Control, 2008 | 7 | 2008 |
| Targeting Lewis Y (LeY) in small cell lung cancer (SCLC) with a humanized monoclonal antibody, hu3S193 LM Krug, D Milton, L Chen, AA Jungbluth, E Quaia, A Nagel, J Jones, ... Journal of Clinical Oncology 24 (18_suppl), 7086-7086, 2006 | 6 | 2006 |
| A model of query performance in dynamic distributed federated databases taking account of network topology A Kawaguchi, A Mowshowitz, A Nagel, A Toce, G Bent, P Stone, ... Annual Conference of the International Technology Alliance, Southampton, UK 29, 2012 | 5 | 2012 |
| Network topology as a cost factor in query optimization A Mowshowitz, A Kawaguchi, A Toce, A Nagel, P Stone, P Dantressangle, ... Annual Conference of the International Technology Alliance, Adelphi, MD 124, 2011 | 5 | 2011 |
| Building a Community Information System for Supporting Disabled Bus Riders and Local Businesses A Kawaguchi, A Nagel, C Chan, NA Parker Web Information Systems and Technologies, 188-201, 2011 | 2 | 2011 |
| Bone marrow dosimetry using 124I-PET J Schwartz, A Nagel, C Divgi, S Larson, J Humm, J O'Donoghue Journal of Nuclear Medicine 48 (supplement 2), 132P-132P, 2007 | | 2007 |
| Utilizzo dell’anticorpo chimerico marcato con 124-I nella diagnosi pre-chirurgica del tumore renale a cellule chiare in pazienti con masse renali operabili. E Quaia, P Russo, D Pryma, N Pandit-Taskar, A Nagel, C Pierre, V Reuter, ... 42° Congresso Nazionale SIRM-Riassunti, 247-247, 2006 | | 2006 |
| Pilot study of iodine-124 labeled chimeric G250 (124I-cG250) in the presurgical diagnosis of clear cell-type renal carcinoma in patients with operable renal masses. E Quaia, P Russo, D Pryma, A Nagel, C Pierre, V Reuter, LJ Old, S Larson, ... Springer Verlgag, 2006 | | 2006 |
| Hu3S193, a humanized monoclonal antibody directed against Lewis Y, demonstrates strong targeting to small cell lung cancer (SCLC) in patients. LM Krug, DT Milton, LC Chen, AA Jungbluth, A Nagel, R Finn, ... CLINICAL CANCER RESEARCH 11 (24), 8980S-8980S, 2005 | | 2005 |
| Radioimmunotherapy of Recurrent Primary CNS Lymphoma with Yttrium-90 Ibritumomab Tiuxetan DA Pryma, J Schwartz, A Nagel, AD Zelenetz, LE Abrey, J Humm, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 32, S206-S206, 2005 | | 2005 |
